GLP-1/beta-catenin/TCF信号通路对糖尿病鼠心肌细胞凋亡的保护作用及机制研究

项目名称： GLP-1/beta-catenin/TCF信号通路对糖尿病鼠心肌细胞凋亡的保护作用及机制研究

项目编号： No.81200602

项目类型： 青年科学基金项目

立项/批准年度： 2013

项目学科： 医学二处

项目作者： 应颖

作者单位： 深圳大学

项目金额： 23万元

中文摘要： 糖尿病心肌病是糖尿病严重的慢性并发症之一。研究表明给予实验对象抗心肌凋亡治疗能有效控制糖尿病心肌病的病程进展。β-catenin/TCF信号通路是调控细胞生存的重要通路。GLP-1通过激活β-catenin/TCF通路抑制胰岛β细胞凋亡，促进β细胞增殖和再生。研究显示GLP-1对心血管具有一定保护作用。然而对GLP-1在糖尿病所致心肌细胞凋亡中的作用及具体机制目前所知甚少。已发现GLP-1受体在心肌细胞广泛表达，而β-catenin/TCF通路活性增强可抑制糖尿病心肌细胞凋亡，提示GLP1可能通过激活β-catenin/TCF通路抑制心肌细胞凋亡。本课题拟明确：GLP-1对高糖培养所致大鼠心肌细胞凋亡及STZ糖尿病大鼠心肌病变的保护作用；GLP-1/β-catenin/TCF通路在保护高糖所致大鼠心肌细胞凋亡中的作用及具体调控机制。本研究将为糖尿病心肌病的预防和治疗提供新的思路和治疗靶点。

中文关键词： 棕榈酸钠；心肌细胞；凋亡；GLP-1；Akt/GSK3beta/beta-catenin

英文摘要： Diabetic cardiomyopathy (DC) is a long-term complication of diabetes. Increasing lines of evidence have shown that therapeutics against cardiomyocyte apoptosis significantly delay the progression of DC. The canonical β-catenin/TCF signaling pathway is important in the modulation of cell proliferation and survival. GLP-1 can inhibit the apoptosis of pancreatic β-cells and induce the proliferation and regenesis of β-cells via the activation of β-catenin/TCF signaling. Recently, GLP-1 has been shown to exert cardiovascular effects in a number of experimental models. Nevertheless, the protective effect of GLP-1 on the cardiomyocyte apoptosis in DC and its underlined mechanism remain largely unknown thus far. GLP-1 receptors are expressed in cardiomyocytes, while the activation of β-catenin/TCF signaling leads to the inhibition of cardiomyocyte apoptosis in DC. We therefore proposed that GLP-1 might protect the cardiomyocyte from apoptosis via activating β-catenin/TCF signaling pathway. The aim of this study is to clarify the protective effect of GLP-1 on the cardiomyocyte apoptosis in high-gluocose culture condition in vitro, and its effect on the diabetic cardiomyopathy in STZ induced diabetic rats in vivo, respectively; to further investigate the role of GLP-1/β-catenin/TCF signaling in the inhibition of cardiomyo

英文关键词： palmitate；cardiomyocyte；apoptosis；GLP-1；Akt/GSK3β/β-catenin